Disposition of 13066 shares by Alison Bauerlein of Sight Sciences at 3.477 subject to Rule 16b-3
| SGHT Stock | USD 3.47 0.20 6.12% |
Slightly above 55% of Sight Sciences' private investors are presently thinking to get in. The analysis of overall sentiment of trading Sight Sciences stock suggests that some investors are interested at this time. Sight Sciences' investing sentiment can be driven by a variety of factors including economic data, Sight Sciences' earnings reports, geopolitical events, and overall market trends.
Filed transaction by Sight Sciences Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Sight Sciences Fundamental Analysis
We analyze Sight Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sight Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sight Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Sight Sciences is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Sight Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sight Sciences stock to make a market-neutral strategy. Peer analysis of Sight Sciences could also be used in its relative valuation, which is a method of valuing Sight Sciences by comparing valuation metrics with similar companies.
Peers
Sight Sciences Related Equities
| OFIX | Orthofix Medical | 13.46 | ||||
| RXST | Rxsight | 1.54 | ||||
| CTKB | Cytek Biosciences | 1.04 | ||||
| TMCI | Treace Medical | 0.36 | ||||
| LUNG | Pulmonx Corp | 0.61 | ||||
| AXGN | Axogen | 0.95 | ||||
| RPID | Rapid Micro | 2.01 | ||||
| EVCM | EverCommerce | 2.72 |
Additional Tools for Sight Stock Analysis
When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.